MOH vs OSCR Stock Comparison
Compare MOH and OSCR across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.
What is the main difference between MOH and OSCR?
OSCR leads the current stock comparison as Oscar Health, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Molina Healthcare, Inc. vs Oscar Health, Inc.
OSCR leads
OSCR leads by 18 AIQ points, primarily on Quality and Momentum. Wall Street currently favors MOH on target upside.
Competitive: 3 of 6 evidence groups support OSCR, and its signal state is cleanly positive.
Molina Healthcare, Inc.
Oscar Health, Inc.
The Algovestiq AIQ Score currently favors OSCR over MOH, 64 versus 46 as of Sep 11, 2026. OSCR's advantage is driven primarily by stronger quality and momentum, while MOH holds the stronger risk resilience profile. OSCR also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors MOH. 3 of 6 covered evidence groups favor OSCR today, and the comparison is rated Competitive on stability: only 3 of 6 covered evidence groups agree. OSCR lead: Stable — the AIQ differential has held near 18 points over 30 sessions.
Compare Molina Healthcare, Inc. and Oscar Health, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price-return comparison using available daily close history.
Total return comparison
Growth of $10,000
Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.
Compare MOH and OSCR against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality31 vs 86OSCR +55
- Risk Resilience57 vs 28MOH +29
- Momentum52 vs 67OSCR +15
- Value50 vs 59OSCR +9
3 of 6 evidence groups favor OSCR. OSCR’s edge is concentrated in quality and momentum; MOH keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.
Largest factor move: Momentum +13
New signals
- MACD Bullish Crossover — bullish, momentum, short horizon
Largest factor move: Momentum +7
No new signals fired.
OSCR's lead narrowed by 3 AIQ points in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — MOH and OSCR both carry a full feed there.
The central trade-off
OSCR (Oscar Health, Inc.): the stronger current systematic profile, led by quality and momentum.
MOH (Molina Healthcare, Inc.): the counter-case, on risk resilience, analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
OSCROSCR on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
MOHMOH on combined revenue and EPS growth.
Value
OSCROSCR on the peer-relative Value factor, by 9 points.
Momentum
OSCROSCR on the Momentum factor, by 15 points.
Lower downside
MOHMOH on Risk Resilience, by 29 points.
Analyst upside
MOHMOH on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors OSCR, analyst targets favor MOH. That disagreement is the most useful thing on this page.
| Measure | MOH | OSCR | Note |
|---|---|---|---|
| Implied upside to target | -2.7% | -15.7% | MOH has more room |
| Target dispersion | +79% | +83.2% | Lower is tighter analyst agreement |
| Consensus | Hold | Hold | Context, not a primary driver |
| Analysts covering | 11 | 8 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor OSCR. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | OSCR | 46 vs 64 |
| Fundamentals | Even | EPS growth 3.4% vs -47.4%; gross margin 34.6% vs 44.9% |
| Valuation | OSCR | Value 50 vs 59 |
| Technicals | OSCR | Price vs 50-day -2.2% vs 7.1%; vs 200-day 12.4% vs 56.9% |
| Risk Resilience | MOH | Risk Resilience 57 vs 28 |
| Analyst expectations | MOH | Target upside -2.7% vs -15.7% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of MOH and OSCR and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is wide at 18 points. (supports the conclusion holding)
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
- Analyst targets on the leader are widely dispersed. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on OSCR.
How the comparison changed
119 daily snapshots · May 4 – Sep 10OSCR lead: Stable — the AIQ differential has held near 18 points over 30 sessions.
- Today
- OSCR +18
- 46 vs 64
- 7 sessions ago
- OSCR +20
- 44 vs 64
- 30 sessions ago
- OSCR +18
- 46 vs 64
- 90 sessions ago
- OSCR +12
- 53 vs 65
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 0 bearish / 1 neutral
- Golden Cross Active — bullish, trend, long horizon (17.16%)
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (3.69%)
- MACD Bullish Crossover — bullish, momentum, short horizon
5 bullish / 0 bearish / 2 neutral
- Golden Cross Active — bullish, trend, long horizon (47.34%)
- Bollinger Band Squeeze — neutral, volatility, short horizon
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved up over the latest session (price +1.97%, AIQ +4 points).
Price and the AIQ Score both moved up over the latest session (price +0.58%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1MOH closes the Quality gap — currently 55 points behind, the largest single contributor to OSCR's edge.
- 2MOH's ATR Expansion - Breakout Mode turns directional — it is neutral today and would confirm a change in trend.
- 3OSCR's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | MOH | OSCR |
|---|---|---|
| Revenue growth (YoY) | 0.7% | 5% |
| EPS growth (YoY) | 3.4% | -47.4% |
| Gross margin | 34.6% | 44.9% |
| Operating margin | 0.7% | 4.1% |
| Return on equity (TTM) | -0.2% | 38.5% |
| Debt to equity | 0.95 | 0.21 |
Performance
OSCR leads 6 of 6 windows| Metric | MOH | OSCR |
|---|---|---|
| 1 week (5 sessions) | -1.2% | 7.4% |
| 1 month (20 sessions) | -2.8% | 10% |
| 3 months (63 sessions) | 1.2% | 17% |
| 6 months (126 sessions) | 36.4% | 143.1% |
| Year to date | 15.4% | 124.7% |
| 1 year (252 sessions) | 14.1% | 60.7% |
Technicals
OSCR has the stronger structure| Metric | MOH | OSCR |
|---|---|---|
| RSI (14) | 54.7 | 55.4 |
| ADX (14) | 11.7 | 17.7 |
| Price vs 50-day | -2.2% | 7.1% |
| Price vs 200-day | 12.4% | 56.9% |
| Volatility (1M, annualized) | 30% | 49.1% |
Risk
MOH is the more resilient| Metric | MOH | OSCR |
|---|---|---|
| Beta | -0.1 | 1.48 |
| Sharpe ratio | 0.39 | 0.98 |
| Sortino ratio | 0.43 | 1.72 |
| Max drawdown | -39.7% | -51.7% |
| Current drawdown | -17.5% | -1.3% |
| Annualized volatility | 53.2% | 70.7% |
| Value at risk (95%) | -4% | -5.8% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, MOH or OSCR?
On the Algovestiq AIQ Score, OSCR is the stronger of the two as of Sep 11, 2026, scoring 64 against MOH's 46. The edge comes from quality and momentum. MOH is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is MOH or OSCR the better buy right now?
OSCR carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Competitive — 3 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor OSCR over MOH?
The composite weights Quality, Value, Momentum and Risk Resilience. OSCR leads Quality by 55 points; MOH leads Risk Resilience by 29 points; OSCR leads Momentum by 15 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, MOH or OSCR?
Analyst price targets imply -2.7% upside for MOH and -15.7% for OSCR, so the Street currently favors MOH. That points the opposite way to the AIQ Score, which favors OSCR. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, MOH or OSCR?
OSCR is the better-valued of the two on the peer-relative Value factor. OSCR on the peer-relative Value factor, by 9 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, MOH or OSCR?
MOH on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, MOH or OSCR?
OSCR on the Momentum factor, by 15 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, MOH or OSCR?
MOH is the more resilient of the two, so the other name carries the higher downside risk. MOH on Risk Resilience, by 29 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is MOH more profitable than OSCR?
OSCR leads on the comparable margin measures — gross margin 34.6% vs 44.9%; operating margin 0.7% vs 4.1%; ttm roe -0.2% vs 38.5%.
Is OSCR's lead over MOH getting stronger or weaker?
OSCR lead: Stable — the AIQ differential has held near 18 points over 30 sessions. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has not changed hands in that window.
What would change the MOH vs OSCR verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: MOH closes the Quality gap — currently 55 points behind, the largest single contributor to OSCR's edge; MOH's ATR Expansion - Breakout Mode turns directional — it is neutral today and would confirm a change in trend; OSCR's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about MOH and OSCR?
MOH: 2 bullish / 0 bearish / 1 neutral. OSCR: 5 bullish / 0 bearish / 2 neutral. The most decision-relevant rule on MOH is Golden Cross Active (bullish, long horizon). On OSCR it is Golden Cross Active (bullish, long horizon).
Compare MOH and OSCR with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.